• EnglishEnglish
    • Deutsch Deutsch
    • Italiano Italiano
    • Français Français
    • 日本語 日本語
    • 한국어 한국어

CISEMA - China Zertifizierung, Einkauf und Qualitätssicherung

  • Services
    • NMPA Registration – Medical Devices and IVDs
    • NMPA Registration & DMF – Pharmaceuticals
    • NMPA Registration – Cosmetics
    • NMPA Registration – Health Food
    • CML (China Manufacture Licence) – Pressure vessels
    • CCC (China Compulsory Certification) – Industrial and consumer goods
    • Others
      • Sourcing and Quality Control
      • Logistics and Customs Support
      • Sales Support
  • Events
    • Trade Fairs & Conferences
    • Seminars
    • Webinars
  • News & Knowledge
    • Regulatory News
      • Medical Devices and IVDs
      • Cosmetics
      • Pharmaceuticals & DMF
      • CCC
      • Pressure Vessels
    • Whitepapers
    • FAQ – NMPA Registration – Medical Devices and IVDs
    • Newsletter Sign Up
    • Others
      • Publications
      • Online Shop
  • About us
    • Partners
    • Company Profile
    • Testimonials
  • Locations
  • Newsletter Sign Up
Contact
  • Home
  • News
  • News
  • CML, SELO
  • Positive development for remote inspections to obtain SELO China manufacturer license

Positive development for remote inspections to obtain SELO China manufacturer license

Friday, 05 March 2021 / Published in CML, SELO, News

Positive development for remote inspections to obtain SELO China manufacturer license

On February 26, 2021, the China Special Equipment and Research Institute published that they conducted the first remote inspection for the authority SELO in January.

To renew an existing manufacturer license or to obtain a new license from the authority SELO for pressure vessels, boilers, safety valves and other special equipment, an factory inspection on-site the manufacturer’s production site was stipulated as mandatory.

According to announcement no. 3/2020 of the authority SAMR (State Administration for Market Regulation) all certification and inspection bodies need to work on implementing an alternative to on-site inspections due to the Covid19 pandemic restrictions.

In 2020, to the best of our current knowledge, no factory inspection was carried out outside the P.R. China for the SELO manufacturer’s licence. The only way for licence holders to continue to export to China was to apply for a temporary validity extension for their expiring licence. Manufacturers without an existing licence were not granted special permits to import and distribute their products in China.

Now, this successful trial certainly will be not the only case and the next months pending inspections are likely to be scheduled as remote inspection.

Related news: Chinese certification authorities published measures to support the containment of the corona virus outbreak

Tagged under: Pressure Vessels, safety valves, SELO

What you can read next

Details You Should Notice for the New Cosmetics Registration and Filing Online Platform
April 2021 China Regulatory Round-up for Medical Devices
China clinical trials gcp
China Clinical Trials GCP – Important Changes for the Administration of Medical Device & IVD Clinical Trials

Search

Categories

  • Fairs & Events
  • News
    • CCC
    • CEL
    • CML, SELO
    • Medical Devices Listing in Hong Kong
    • NMPA Registration in China
      • Cosmetics
      • Health Food
      • Medical Device
      • Pharmaceuticals & DMF
    • RoHS
    • Voluntary Product Certification
  • Publications
  • Seminars
  • Uncategorized
  • Webinars

Recent Posts

  • Submission of safety information for cosmetics ingredients

    Submission of safety information for cosmetics raw materials – Draft guidelines issued

    Submission of safety information for cosmetics ...
  • avoid animal testing in Chinaweb-2023

    How to avoid animal testing in China for cosmetics | Cisema Webinar

    China’s beauty and cosmetic market has be...
  • guidelines for medical devices registration

    Guidelines for medical devices registration in China – New development plans in 2023

    Guidelines for medical devices registration in ...
  • China DMF of API

    China DMF of API, Excipient & Packaging Materials: Market & Regulatory | Cisema Webinar

    “China DMF of API, Excipient & Packag...
  • pre-phase III drug clinical trial meeting guidelines

    Pre-phase III drug clinical trial meeting guidelines released

    Pre-phase III drug clinical trial meeting guide...

Archive

Cisema

With twelve locations and over ninety highly qualified employees, Cisema can offer you optimal support in China.

Services

  • Certification
  • Sourcing and Quality Control
  • Logistics and Customs Support
  • Sales Support

Dialogue

  • Contact us
  • Newsletter Signup
  • Events
  • News & Knowledge
  • Partners

Company

  • GTC
  • Privacy Statement
  • Legal Notice
  • About us
  • Locations
  • GET SOCIAL

© 2021 Cisema. All rights reserved.

TOP